NCT02087007 - A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Vasospastic Angina

Interventions

DRUG

Cilostazol

100mg oral tablets bid during 2 weeks after dosing of 50mg oral tablets bid during 2 weeks

DRUG

placebo

100mg oral placebo tablets bid during 2 weeks after dosing of 50mg oral placebo tablets bid during 2 weeks

Trial Locations (1)

Yangsan Busan University Hospital, Busan